The global challenge of antimicrobial resistance: Insights from economic analysis

International Journal of Environmental Research and Public Health

Volumn 7, Issue 8, 2010, Pages 3141-3149

  Eggleston, Karen ^a   Zhang, Ruifang ^b   Zeckhauser, Richard J ^c  

^a STANFORD UNIVERSITY   (United States)

^b Goldman Sachs Group   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Antimicrobial resistance; Behavioral economics; Drug resistance; Economic analysis

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG CHOICE; DRUG COST; DRUG USE; ECONOMIC EVALUATION; GROWTH INHIBITION; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH; NONHUMAN; PATIENT ATTITUDE; PUBLIC HEALTH; SOCIAL ASPECT; SOCIAL EVOLUTION;

EID: 78649593482     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph7083141     Document Type: Article

References (29)

1. Levy, S.B. Multidrug resistance: A sign of the times. N Engl. J. Med. 1998, 338, 1376-1378.
2. Cohen, M.L. Epidemiology of drug resistance: Implications for a post-antimicrobial era. Science 1992, 257, 1050-1055.
3. Bancroft, E.A. Antimicrobial resistance: it's not just for hospitals. JAMA 2007, 298, 1803.
4. Shah, N.S.; Wright, A.; Bai, G.H.; Barrera, L.; Boulahbal, F.; Martin-Casabona, N.; Drobniewski, F.; Gilpin, C.; Havelková, M.; Lepe, R.; Lumb, R.; Metchock, B.; Portaels, F.; Rodrigues, M.F.; Rüsch-Gerdes, S.; Van Deun, A.; Vincent, V.; Laserson, K.; Wells, C.; Cegielski, J.P. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 2007, 13, 380-387; Available online: http://www.cdc.gov/eid/content/13/3/380.htm/ (accessed on 1 July 2010).
5. Harbarth, S.; Samore, M.H. Antimicrobial resistance determinants and future control. Emerg. Infect. Dis. 2005, 11, 794-801.
6. Moellering, R.C.; Graybill, J.R.; McGowan, J.E.; Corey, L. Antimicrobial resistance prevention initiative-an update: Proceedings of an expert panel on resistance. AJIC 2007, 35, 1-23.
7. Song, J.H.; Jung, S.I.; Ko, K.S.; Kim, N.Y.; Son, J.S.; Chang, H.H; Ki, H.K.; Oh, W.S.; Suh, J.Y.; Peck, K.R.; Lee, N.Y.; Yang, Y.H.; Lu, Q.; Chongthaleong, A.; Chiu, C.H.; Lalitha, M.K.; Perera, J.; Yee, T.T.; Kumarasinghe, G.; Jamal, F.; Kamarulzaman, A.; Parasakthi, A.; Van, P.H.; Carlos, C.; So, T.; Ng, T.K.; Shibl, A. High prevalence of antimicrobial resistance among clinical streptococcus pneumoniae isolates in Asia (an ANSORP Study). Antimicrob. Agents Chemother. 2004, 48, 2101-2107.
8. Tiemersma, E.W.; Bronzwaer, S.L.; Lyytikainen, O.; Degener, J.E.; Schrijnemakers, P.; Bruinsma, N.; Monen, J.; Witte, W.; Grundmann, H.; European antimicrobial resistance surveillance system participants. methicillin-resistant staphylococcus aureus in Europe, 1999- 2002. Emerg. Infect. Dis. 2004, 10, 1627-1634.
9. Davies, J. Bacteria on the rampage. Nature 1996, 383, 219-220.
10. Gold, H.S.; Mollering, R.D. Antimicrobial-drug resistance. N. Engl. J. Med. 1996, 335, 1445-1453.
11. Cosgrove, S.E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin. Infect. Dis. 2006, 42, S82-S89.
12. Okeke, I.N.; Laxminarayan, R.; Bhutta, Z.A.; Duse, A.G.; Jenkins, P.; O'Brien, T.F.; Pablos-Mendez, A.; Klugman, K.P. Antimicrobial resistance in developing countries: Recent trends and current status. Lancet Infect. Dis. 2005, 5, 481-493.
13. Okeke, I.N.; Klugman, K.P.; Bhutta, Z.A.; Duse, A.G.; Jenkins, P.; O'Brien, T.F.; Pablos-Mendez, A.; Laxminarayan, R. Antimicrobial resistance in developing countries: Strategies for containment. Lancet Infect. Dis. 2005, 5, 568-580.
14. Institute of Medicine. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. National Academies Press: Washington, DC, USA, 2004.
15. Laxminarayan, R.; Over, M.; Smith, D. Will a global subsidy of new antimalarials delay the emergence of resistance and save lives? Health Affair. 2006, 25, 325-336.
16. Laibson, D. Golden eggs and hyperbolic discounting. Quart. J. Econ. 1997, 112, 443-477.
17. O'Donoghue, T.; Rabin, M. Doing it now or later. Amer. Econ. Rev. 1999, 89, 103-124.
18. World Health Organization. Use of antimicrobials outside human medicine and resultant antimicrobial resistance in humans. Fact sheet N°268; WHO: Geneva, Switzerland, 2002 Available online: http://www.who.int/mediacentre/factsheets/fs268/en/ (accessed on 24 February 2010).
19. Schneider, K.; Garrett, L. Non-therapeutic Use of Antibiotics in Animal Agriculture, Corresponding Resistance Rates, and What Can be Done About It; Council on Foreign Relations. Center for Global Development: Washington, DC, USA, 2009; Available online: http://www.cgdev.org/content/article/detail/1422307/#v/ (accessed on 24 February 2010).
20. Laxminarayan, R.; Malani, A; Howard, D.; Smith, D. Extending the Cure: Policy responses to the growing threat of antibiotic resistance. Resources for the Future (RFF) Report; RFF: Washington, DC, USA, 2007. Available online: http://www.rff.org/RFF/Documents/ETC_fullreport.pdf/ (accessed on 24 February 2010).
21. Zhang, R.; Eggleston, K.N.; Rotimi, V.; Zeckhauser, R.J. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Glob. Health 2006, 2, 6; Available online: http://www.globalizationandhealth.com/content/2/1/6/ (accessed on 1 July 2010).
22. Espinal, M.A.; Laszlo, A.; Simonsen, L.; Boulahbal, F.; Kim, S.J.; Reniero, A.; Hoffner, S.; Rieder, H.L.; Binkin, N.; Dye, C.; Williams, R.; Raviglione, M.C. Global trends in resistance to antituberculosis drugs. N. Engl. J. Med. 2001, 344, 1294-1303.
23. Call, D.R.; Bakko, M.K.; Krug, M.J.; Roberts, M.C. Identifying antimicrobial resistance genes with DNA microarrays. Antimicrob. Agents Chemother. 2003, 47, 3290-3295.
24. Rudholm, N. Economic implications of antibiotic resistance in a global economy. J. Health Econ. 2002, 21, 1071-1083.
25. Deaton, A. Health in an age of globalization. Brookings Trade Forum 2004, 83-110. Available online: http://ideas.repec.org/p/nbr/nberwo/10669.html/ (accessed on 28 July 2010).
26. Kwon, S. Payment system reform for health care providers in Korea. Health Policy Plan. 2002, 18, 84-92.
27. Heddini, A.; Cars, O.; Sun, Q.; Tomson, G. Antibiotic resistance in China-a major future challenge. Lancet 2009, 373, 30.
28. Portney, P.R. Environmental problems and policy: 2000-2050. J. Econ. Perspect. 2000, 14, 199-206.
29. Pachauri, R.K. Acceptance speech for the Nobel Peace Prize awarded to the Intergovernmental Panel on Climate Change (IPCC), Oslo, 10 December 2007. Available Online: http://www.ipcc.ch/graphics/speeches/nobel-peace-prize-oslo-10-december-2007.pdf/ (accessed on 31 December 2009).